US FDA Reassures ALS Patients In Final Development Guidance

 
• By Derrick Gingery
nerve cells, concept for neurodegenerative and neurological disease
The FDA encouraged development of endpoints that measure function in daily living in final ALS drug development guidance. • Source: Shutterstock

More from R&D

More from Pink Sheet